IMUX   $0.6235  -2.15% Market Closed

Immunic, Inc.
Total Cash 79.70M
totalCashPerShare 0.885
EBITDA -93.53M
Total Debt 955.00K
quickRatio 3.581
currentRatio 3.747
Total Revenue
debtToEquity 1.502
Revenue/Share
ROA -0.66802
ROE -1.4347
grossProfits
freeCashflow -42.51M
operatingCashflow -72.34M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 28.45M
forwardPE -1.84375
floatShares 52.16M
sharesOutstanding 90.08M
sharesShort 3.47M
sharesShortPriorMonth 2.35M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.03%
heldPercentInstitutions 0.63%
Short Ratio help_outline 5.76%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue 0.706
Price To Book help_outline 1.67
earningsQuarterlyGrowth
netIncomeToCommon -95.31M
trailingEps -1.50%
forwardEps -0.64%
enterpriseToEbitda -0.30
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.22 3Q 2024
institutionsCount 71
lastUpdated Nov. 7, 2024, 3:26 a.m.